Medicenna Therapeutics Corp. announced the formation of its Scientific Advisory Board (SAB) comprised of thought leaders in cancer immunotherapy, immuno-engineering and immune monitoring. Chaired by Sergio Quezada, Ph.D., the SAB will work cohesively with management to explore the full potential of Medicenna's Superkine platform.

The members are Burkhard Becher, Ph.D. He is a Professor at the University of Zurich where he serves as Chair of the Institute of Experimental Immunology. David Mooney, Ph.D. is the Robert Pinkas Family Professor of Bioengineering in the Harvard School of Engineering and Applied Sciences, and a founding core faculty member of the Wyss Institute for Biologically Inspired Engineering at Harvard University. William Redmond, Ph.D. is Director of the Immune Monitoring Laboratory and Full Member at the Earle A. Chiles Research Institute (EACRI) at the Providence Cancer Institute.